Commercial name: Erythrocin 250 ,500 mg tab, 100mg/5ml susp,100mg/ml ped. drops;
    
        Etrocin, Eryster: 250mg tab, 100mg/5ml dry syp, Emthro250mg tab, 125mg/5ml suspension.
    
    
    
        Acts by inhibiting bacterial protein synthesis. It interferes with 50 S ribosome
        sub units and interferes with translocation.
    
    
    
        - 
            Alternative to penicillin G and other penicillins for the treatment of patients
            hypersensitive to penicillin.
        
- 
            Treatment of upper and lower respiratory tract, skin and soft tissue infections
            of mild to moderate severity.
        
- As a first choice of drugs for atypical pneumonia and whooping cough.
        - Psuedomembranous colitis and hepatic dysfunction reported. 
- Contraindicated in concomitant terfenadine.
        - 
            Nausea, vomiting, diarrhoea, anorexia, abdominal pain, hepatic dysfunction, abnormal
            LFTs, allergic reactions and superinfection.
        
        Commercial name: Claribid 250, 500 mg tab, 250mg/5ml dry syp; Clarimac 250, 500mg
        tabs.
    
    
    
        Acts by inhibiting bacterial protein synthesis. It interferes with 50S ribosome
        sub units and interferes with translocation.
    
    
    
        - 
            Treatment of upper and lower respiratory tract infections, sinusitis, otitis media,
            atypical pneomonia skin and skin structure infections due to strp. pyogenes and
            staph. aureus.
        
- 
            It is the first line of treatment in MAC infections in AIDS patients and second
            line of treatment for other atypical mycobacteria diseases in leprosy patients.
        
        - 
            W/P: Avoid in pregnancy. Psuedomembranous colitis reported. Adjust dose with severe
            renal impairment.
        
- Contraindicated in concomitant cisapride, pimozide, terfenadine. 
        - 
            Nausea, diarrhoea, abnormal taste, dyspepsia, abdominal pain, headache, vomiting,
            rash.
        
        Commercial name: Azithral 250, 500mg cap and 250 mg /5ml dry syr; Aziwok 250 mg
        cap, 100mg, 100mg/5ml and 200mg/5ml susp.; Aziwin 100, 250, 500 mg tab.
    
    
    
        Acts by inhibiting bacterial protein synthesis. It interferes with 50S ribosome
        sub units and interferes with translocation.
    
    
    
        - 
            It is the first choice of treatment in Legionairre's pneumonia, Chalymidial tracomatis.
        
- 
            Other indications include pharyngitis, tonsillitis, sinusitis, acute exacerbations
            of chronic bronchitis, streptococcal and some staphylococcal skin and soft tissue
            infections and gonorrhea.
        
        - 
            Monitor theophylline terfenadine, cyclosporine, phenytoin and warfarin. May increase
            digoxin and carbamazepine level.
        
        - Mild gastric upset, abdominal pain headache and dizziness.